SMOX
Horizon Small/Mid Cap Core Equity ETF
The Horizon Small/Mid Cap Core Equity ETF seeks to provide long-term capital appreciation by investing primarily in a diversified portfolio of small and mid-cap U.S. equities.
US
EQUITY
Active
MANAGEMENT STYLE
$ 146.0 M
ASSETS UNDER MGMT
75 bp
EXPENSES
Fund Basics
| Inception date | Dec 02, 2025 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| SYNNEX CORP | 1.3 % |
| ALLEGHENY TECHNOLOGIES INC | 1.2 % |
| TWILIO, INC. CLASS A | 1.2 % |
| TECHNIPFMC PLC | 1.1 % |
| TENET HEALTHCARE CORP | 1.1 % |
| RELIANCE STEEL & ALUMINUM | 1.1 % |
| UNITED THERAPEUTICS CORP | 1.0 % |
| OKTA, INC. CLASS A | 1.0 % |
| ROKU, INC. CLASS A | 1.0 % |
| MA-COM TECHNOLOGY SOLUTIONS | 0.9 % |
Constituent Breakdown
| Number of holdings | 282 |
| Herfindahl-Hirschman Index | 60 |
| Wgt avg mkt cap (mns) | $11,520 |
| Large cap (>$10bn) | 51.2% |
| Mid cap ($2-10bn) | 44.7% |
| Small cap (<$2bn) | 0.2% |
| Developed mkts. | 96.1% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 95.2 % |
 |
BRITAIN | 2.3 % |
 |
BERMUDA | 1.3 % |
 |
CANADA | 0.9 % |
Historical Performance
Standardized Performance (as of 08/31/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 19.0% | -- | -- | -- | -- | -- | -- | 19.4% |
| Dividend Yield | 0.0% | -- | -- | -- | -- | -- | -- | 0.1% |
| Total Returns | 19.0% | -- | -- | -- | -- | -- | -- | 19.5% | Ann. Volatility | 15.1% | -- | -- | -- | -- | -- | -- | 14.7% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.00 | 0% |
| MSCI EAFE | 0.00 | 0% |
| MSCI Emg Mkts | 0.00 | 0% |
Liquidity Measures
| Avg. volume (000) | 56 |
| ADV traded (mns) | $2 |
| Turnover | 1.2% |
| Avg. Bid/Ask (% of price) | 0.40% |
Technical Indicators
| 30d moving avg. (EMA) | $30.42 |
| Relative strength (RSI) | 62 |
| MACD/Signal | 0.27/0.20 |
| Bollinger Bands (Upper/Lower) | $31.26/$29.68 |
| Short interest (% of AUM) | 0.6% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. SMOX |
Expenses vs. SMOX |
ALTAR Score™ vs. SMOX |
|---|---|---|---|---|
| MDY | SPDR S&P Midcap 400 ETF Trust | 53.3% | -52 bp | +0.6% |
| IJH | iShares Core S&P Mid-Cap ETF | 51.5% | -70 bp | +0.8% |
| SPMD | State Street SPDR Portfolio S&P 400 Mid Cap ETF | 51.5% | -72 bp | +0.8% |
| IVOO | Vanguard S&P Mid-Cap 400 ETF | 51.4% | -68 bp | +0.8% |
| XJH | iShares ESG Screened S&P Mid-Cap ETF | 50.8% | -63 bp | +0.6% |
| QVMM | Invesco S&P MidCap 400 QVM Multi-factor ETF | 49.3% | -60 bp | +0.8% |
| MIDE | Xtrackers S&P MidCap 400 ESG ETF | 45.7% | -60 bp | +1.4% |
| SMDX | Intech S&P Small-Mid Cap Divers Alp ETF | 44.0% | -40 bp | +1.2% |
| JMEE | JPMorgan Market Expansion Enhanced Equity ETF | 42.9% | -51 bp | +0.5% |
| IVOG | Vanguard S&P Mid-Cap 400 Growth ETF | 42.1% | -65 bp | -1.0% |
Risk and Returns: SMOX vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 9/6/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
6.0%
ALTAR SCORE™
65th
PERCENTILE
OVERWEIGHT
ETFRC RATING
There are 1,408 funds in the US Equity category with an average
ALTAR Score™ of 5.2% and a standard deviation
of 2.0%. SMOX's ALTAR Score™ is approximately 0.4 standard
deviations above the category average. This places SMOX in the 65th percentile
among funds in the category.
Sell-Side Consensus
$31.8
PRICE TARGET
+5.4%
UPSIDE